As we enter the second half of 2025, the article emphasizes the importance of monitoring high-performing dividend stocks like CVS Health. The stock has surged by 56% so far, driven by impressive earnings and favorable analyst outlooks. With a projected EPS growth and strong price targets, CVS stands out despite previous struggles. The commentary suggests staying engaged with top dividend stocks while considering market dynamics and potential EPS growth, providing investors an opportunity for continued gains as they assess the second half of the year.
CVS Health is back in a big way after gaining 56% in the first half, recovering much of the ground lost in 2024.
TD Cowen has a lofty $95 per-share price target, citing it as one of its best ideas for 2025.
Collection
[
|
...
]